Krakoff I H, Newman R A, Goldberg R S
Cancer. 1979 Nov;44(5):1722-7. doi: 10.1002/1097-0142(197911)44:5<1722::aid-cncr2820440528>3.0.co;2-c.
Gallium nitrate, administered intravenously to patients with advanced cancer, produced renal functional abnormalities consistently at a dose of 750 mg/m2. The toxicity at that dose could be modified by fluid loading and osmotic diuresis. Pharmacokinetic studies revealed a biphasic half-life, (T 1/2 alpha = 87 minutes and T 1/2 beta = 24.5 hours). Osmotic diuresis reduced the urinary concentration of gallium but did not affect serum levels or clearance.
硝酸镓静脉注射给晚期癌症患者时,剂量为750mg/m²时会持续产生肾功能异常。该剂量下的毒性可通过补液和渗透性利尿来减轻。药代动力学研究显示出双相半衰期,(α相半衰期=87分钟,β相半衰期=24.5小时)。渗透性利尿降低了尿中镓的浓度,但不影响血清水平或清除率。